跳至主要内容
临床试验/CTRI/2025/09/094926
CTRI/2025/09/094926尚未招募不适用

To evaluate safety and efficacy of skin care formulation in terms of reduction in under eye wrinkles and fine lines and reduction in crows feet wrinkles and fine lines on healthy human subjects

ClayCo. Cosmetics Pvt. Ltd.1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2025年9月24日

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
36
试验地点
1
主要终点
Reduction in under eye wrinkles & fine lines and reduction in crows feet wrinkles & fine lines

研究概览

简要总结

OBJECTIVE: The objective of this study will be to evaluate the safety & efficacy of a skin care formulation in terms of reduction in under eye wrinkles & fine lines and reduction in crows feet wrinkles & fine lines on healthy human subjects. The evaluation will be performed using:Subject Self Evaluation,Dermatological Evaluation: Cosmetic Acceptability, Dermatological Evaluation: Efficacy

 POPULATION:36 (18 female & 18 male) subjects will be selected for the study. The subjects selected for this study will be healthy females, aged between 35 to 55 years, having under eye wrinkles & fine lines and  crow’s feet wrinkles & fine lines.

 STUDY DURATION Duration: 28 days following the first application of the product.

研究设计

研究类型
Interventional
分配方式
Na
盲法
Participant and Outcome Assessor Blinded

入排标准

年龄范围
35.00 Year(s) 至 55.00 Year(s)(—)
性别
All

入选标准

  • Indian male & female subjects 2)Healthy subjects 3)Skin is healthy on the studied anatomic unit 4)Having under eye wrinkles & fine lines and crows feet wrinkles & fine lines.

排除标准

  • For Females:Being pregnant or breastfeeding or having stopped to breastfeed in the past three months.
  • Having refused to give his/her assent by not signing the consent form and Informed consent form
  • Taking part in another study liable to interfere with this study
  • Being known diabetic case
  • Known asthma case
  • Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area (except for specific studies on a determined dermatosis)
  • Being known thyroid case
  • Being epileptic.
  • Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes or corticosteroid by any route (the only medication permitted is paracetamol)
  • Known case of hypersensitivity.
  • Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products.
  • Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.

结局指标

主要结局

Reduction in under eye wrinkles & fine lines and reduction in crows feet wrinkles & fine lines

时间窗: Baseline, Day 7, Day 14 and Day28

次要结局

未报告次要终点

研究者

发起方
ClayCo. Cosmetics Pvt. Ltd.
申办方类型
Other [Personal Care or Beauty Industry]
责任方
Principal Investigator
主要研究者

Dr Niharika Salian

MASCOT-SPINCONTROL India Pvt. Ltd.

研究点 (1)

Loading locations...

相似试验